DOI QR코드

DOI QR Code

Systematic Review and Meta-Analysis of Antibiotic-Impregnated Shunt Catheters on Anti-Infective Effect of Hydrocephalus Shunt

  • Zhou, Wen-xiu (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Hou, Wen-bo (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Zhou, Chao (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Yin, Yu-xia (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Lu, Shou-tao (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Liu, Guang (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Fang, Yi (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Li, Jian-wen (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Wang, Yan (National United Engineering Laboratory for Biomedical Material Modification) ;
  • Liu, Ai-hua (Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University) ;
  • Zhang, Hai-jun (National United Engineering Laboratory for Biomedical Material Modification)
  • Received : 2019.10.31
  • Accepted : 2020.02.04
  • Published : 2021.03.01

Abstract

Objective : Shunt infection is a common complication while treating hydrocephalus. The antibiotic-impregnated shunt catheter (AISC) was designed to reduce shunt infection rate. A meta-analysis was conducted to study the effectiveness of AISCs in reduction of shunt infection in terms of age, follow-up time and high-risk patient population. Methods : This study reviewed literature from three databases including PubMed, EMBASE, and Cochrane Library (from 2000 to March 2019). Clinical studies from controlled trials for shunt operation were included in this analysis. A subgroup analysis was performed based on the patient's age, follow-up time and high-risk population. The fixed effect in RevMan 5.3 software (Cochrane Collaboration) was used for this meta-analysis. Results : This study included 19 controlled clinical trials including 10105 operations. The analysis demonstrated that AISC could reduce the infection rate in shunt surgery compared to standard shunt catheter (non-AISC) from 8.13% to 4.09% (odds ratio [OR], 0.48; 95% confidence interval [CI], 0.40-0.58; p=0.01; I2=46%). Subgroup analysis of different age groups showed that AISC had significant antimicrobial effects in all three groups (adult, infant, and adolescent). Follow-up time analysis showed that AISC was effective in preventing early shunt infections (within 6 months after implant). AISC is more effective in high-risk population (OR, 0.24;95% CI, 0.14-0.40; p=0.60; I2=0%) than in general patient population. Conclusion : The results of meta-analysis indicated that AISC is an effective method for reducing shunt infection. We recommend that AISC should be considered for use in infants and high-risk groups. For adult patients, the choice for AISC could be determined based on the treatment cost.

Keywords

References

  1. Adams DJ, Rajnik M : Microbiology and treatment of cerebrospinal fluid shunt infections in children. Curr Infect Dis Rep 16 : 427, 2014 https://doi.org/10.1007/s11908-014-0427-8
  2. Albanese A, De Bonis P, Sabatino G, Capone G, Marchese E, Vignati A, et al. : Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 151 : 1259-1263, 2009 https://doi.org/10.1007/s00701-009-0317-2
  3. Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML : Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21 : 56-61, 2005 https://doi.org/10.1007/s00381-004-1052-x
  4. Bayston R : Hydrocephalus shunt infections. J Antimicrob Chemother 34 Suppl A : 75-84, 1994 https://doi.org/10.1093/jac/34.suppl_A.75
  5. Bayston R, Grove N, Siegel J, Lawellin D, Barsham S : Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52 : 605-609, 1989 https://doi.org/10.1136/jnnp.52.5.605
  6. Bayston R, Lari J : A study of the sources of infection in colonised shunts. Dev Med Child Neurol 16(6 Suppl 32) : 16-22, 1974 https://doi.org/10.1111/j.1469-8749.1974.tb03443.x
  7. Braga MH, Carvalho GT, Brandão RA, Lima FB, Costa BS : Early shunt complications in 46 children with hydrocephalus. Arq Neuropsiquiatr 67(2A) : 273-277, 2009 https://doi.org/10.1590/S0004-282X2009000200019
  8. Choux M, Genitori L, Lang D, Lena G : Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 77 : 875-880, 1992 https://doi.org/10.3171/jns.1992.77.6.0875
  9. Choux M, Lena G, Genitori L, Empime E, Riss JM : Shunt Implantation-Toward Zero Infection : Childs Nervous System. New York : Springer, 1988, p181
  10. Enger PO, Svendsen F, Wester K : CSF shunt infections in children: experiences from a population-based study. Acta Neurochir (Wien) 145 : 243-248; discussion 248, 2003 https://doi.org/10.1007/s00701-002-1068-5
  11. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M : Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 1 : 444-450, 2008 https://doi.org/10.3171/PED/2008/1/6/444
  12. Eymann R, Steudel WI, Kiefer M : Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis. Klin Padiatr 221 : 69-73, 2009 https://doi.org/10.1055/s-0028-1119397
  13. Farber SH, Parker SL, Adogwa O, McGirt MJ, Rigamonti D : Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience. Neurosurgery 69 : 625-629; discussion 629, 2011 https://doi.org/10.1227/NEU.0b013e31821bc435
  14. Farber SH, Parker SL, Adogwa O, Rigamonti D, McGirt MJ : Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients. World Neurosurg 74 : 528-531, 2010 https://doi.org/10.1016/j.wneu.2010.07.014
  15. George R, Leibrock L, Epstein M : Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51 : 804-811, 1979 https://doi.org/10.3171/jns.1979.51.6.0804
  16. Govender ST, Nathoo N, van Dellen JR : Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99 : 831-839, 2003 https://doi.org/10.3171/jns.2003.99.5.0831
  17. Gutierrez-Gonzalez R, Boto GR : Do antibiotic-impregnated catheters prevent infection in CSF diversion procedures? Review of the literature. J Infect 61 : 9-20, 2010 https://doi.org/10.1016/j.jinf.2010.03.030
  18. Gutierrez-Gonzalez R, Boto GR, Fernandez-Perez C, del Prado N : Protective effect of rifampicin and clindamycin-impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures. BMC Neurol 10 : 93, 2010 https://doi.org/10.1186/1471-2377-10-93
  19. Harrop JS, Sharan AD, Ratliff J, Prasad S, Jabbour P, Evans JJ, et al. : Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery 67 : 187-191; discussion 191, 2010 https://doi.org/10.1227/01.NEU.0000370247.11479.B6
  20. Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL : The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 24 : 557-562, 2008 https://doi.org/10.1007/s00381-007-0521-4
  21. Higgins JP, Wells GA : Cochrane handbook for systematic reviews of interventions. Hoboken : John Wiley & Sons, 2011
  22. Jaeger W, Lee S, Vineet D, Keil A, Agarwal N, Rao S : Ventriculoperitoneal shunts in neonates: a retrospective study of outcomes with anti-biotic-impregnated catheters and a modified peri-operative antibiotic protocol. Br J Neurosurg 31 : 672-676, 2017 https://doi.org/10.1080/02688697.2017.1368450
  23. James G, Hartley JC, Morgan RD, Ternier J : Effect of introduction of antibiotic-impregnated shunt catheters on cerebrospinal fluid shunt infection in children: a large single-center retrospective study. J Neurosurg Pediatr 13 : 101-106, 2014 https://doi.org/10.3171/2013.10.PEDS13189
  24. James HE, Bradley JS : Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days. Pediatr Neurosurg 44 : 104-111, 2008 https://doi.org/10.1159/000113111
  25. Kan P, Kestle J : Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 23 : 773-777, 2007 https://doi.org/10.1007/s00381-007-0296-7
  26. Kandasamy J, Dwan K, Hartley JC, Jenkinson MD, Hayhurst C, Gatscher S, et al. : Antibiotic-impregnated ventriculoperitoneal shunts-a multicentre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 27 : 575-581, 2011 https://doi.org/10.1007/s00381-010-1290-z
  27. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al. : Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 33 : 230-236, 2000 https://doi.org/10.1159/000055960
  28. Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME : Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg 122 : 1096-1112, 2015 https://doi.org/10.3171/2014.12.JNS14908
  29. Lane JD, Mugamba J, Ssenyonga P, Warf BC : Effectiveness of the Bactiseal Universal Shunt for reducing shunt infection in a sub-Saharan African context: a retrospective cohort study in 160 Ugandan children. J Neurosurg Pediatr 13 : 140-144, 2014 https://doi.org/10.3171/2013.11.PEDS13394
  30. Mbabazi-Kabachelor E, Shah M, Vaughan KA, Mugamba J, Ssenyonga P, Onen J, et al. : Infection risk for Bactiseal Universal Shunts versus Chhabra shunts in Ugandan infants: a randomized controlled trial. J Neurosurg Pediatr 23 : 397-406, 2019 https://doi.org/10.3171/2018.10.PEDS18354
  31. Moher D, Liberati A, Tetzlaff J, Altman DG : Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151 : 264-269, 2009 https://doi.org/10.7326/0003-4819-151-4-200908180-00135
  32. Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, et al. : Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 25 : 77-83; discussion 85, 2009 https://doi.org/10.1007/s00381-008-0743-0
  33. Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L : Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems. J Neurosurg 122 : 443-448, 2015 https://doi.org/10.3171/2014.10.JNS13395
  34. Pattavilakom A, Kotasnas D, Korman TM, Xenos C, Danks A : Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery 58 : 930-935; discussion 930-935, 2006 https://doi.org/10.1227/01.NEU.0000210155.65102.E7
  35. Pattavilakom A, Xenos C, Bradfield O, Danks RA : Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 14 : 526-531, 2007 https://doi.org/10.1016/j.jocn.2006.11.003
  36. Piatt JH Jr : Cerebrospinal fluid shunt failure: late is different from early. Pediatr Neurosurg 23 : 133-139, 1995 https://doi.org/10.1159/000120950
  37. Pople IK, Bayston R, Hayward RD : Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77 : 29-36, 1992 https://doi.org/10.3171/jns.1992.77.1.0029
  38. Prusseit J, Simon M, von der Brelie C, Heep A, Molitor E, Volz S, et al. : Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. Pediatr Neurosurg 45 : 325-336, 2009 https://doi.org/10.1159/000257520
  39. Raffa G, Marseglia L, Gitto E, Germano A : Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants. Childs Nerv Syst 31 : 1129-1138, 2015 https://doi.org/10.1007/s00381-015-2685-7
  40. Rehman AU, Rehman TU, Bashir HH, Gupta V : A simple method to reduce infection of ventriculoperitoneal shunts. J Neurosurg-Pediatr 5 : 569-572, 2010 https://doi.org/10.3171/2010.2.PEDS09151
  41. Richards HK, Seeley HM, Pickard JD : Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. J Neurosurg Pediatr 4 : 389-393, 2009 https://doi.org/10.3171/2009.4.PEDS09210
  42. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE : Do antibioticimpregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 7 : 38, 2007 https://doi.org/10.1186/1471-2334-7-38
  43. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI : Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 23 : 867-871, 2007 https://doi.org/10.1007/s00381-007-0334-5
  44. Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, et al. : Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103(2 Suppl) : 131-136, 2005
  45. Steinbok P, Milner R, Agrawal D, Farace E, Leung GK, Ng I, et al. : A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus. Neurosurgery 67 : 1303-1310, 2010 https://doi.org/10.1227/NEU.0b013e3181f07e76
  46. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. : ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355 : i4919, 2016 https://doi.org/10.1136/bmj.i4919
  47. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. : Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 : 2008-2012, 2000 https://doi.org/10.1001/jama.283.15.2008
  48. Thomas R, Lee S, Patole S, Rao S : Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis. Br J Neurosurg 26 : 175-184, 2012 https://doi.org/10.3109/02688697.2011.603856
  49. Vinchon M, Lemaitre MP, Vallee L, Dhellemmes P : Late shunt infection: incidence, pathogenesis, and therapeutic implications. Neuropediatrics 33 : 169-173, 2002 https://doi.org/10.1055/s-2002-34490
  50. Yang B, Song Y, Gao P, Bao N : Prevention of infection by antibioticimpregnated shunts after pediatric hydrocephalus treatment: a single center, retrospective study in China. Clin Neurol Neurosurg 151 : 92-95, 2016 https://doi.org/10.1016/j.clineuro.2016.10.009